Medical Xpress December 31, 2024
Arthur Allen

Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that shape the U.S. drug market. Her job, as a policy advocate at drugmaker Johnson & Johnson, was to tell patient and physician groups about the PBMs’ role in high drug prices.

Armed with that knowledge, Lewandowski filed a potentially groundbreaking lawsuit in February. Rather than targeting the PBMs, however, she went after a big company that uses one—her own employer, Johnson & Johnson.

Lewandowski charges in her lawsuit that by contracting with the PBM Express Scripts, which is part of the insurance giant Cigna, Johnson & Johnson—which fired her in April—failed in its duty to ensure reasonable drug prices for its more than 50,000 U.S. employees.

By...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
NCPA to DOGE: Looking for Waste, Fraud, and Abuse? We Have Suggestions!
The PBM Bill Failed. Americans Dodged A Bullet.
2024’s Biggest AI Stories
Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals

Share This Article